Chr | chr5 |
start | 43571594 |
end | 43603230 |
lncRNA name | NNT-AS1 |
entrez id | 100652772 |
hgnc id | HGNC:49005 |
ensg id | ENSG00000248092 |
refseq id | NR_073113 |
methods | qPCR, Western blot etc. |
regulated | up-regulated |
function description | Loss of function assay was carried out to detect the effects of silenced NNT-AS1 on proliferation, metastasis and EMT process of BC cells. Subcellular fractionation assay demonstrated that NNT-AS1 was located in the cytoplasm of BC cells. we found the combination between NNT-AS1 and miR-142-3p through conducting bioinformatics analysis, RIP and luciferase reporter assays. Similarly, the combination between miR-142-3p and ZEB1 was verified. Finally, the recue assays were carried out to demonstrate the effects of NNT-AS1/miR-142-3p/ZEB1 axis on the biological behaviors of BC cells.All the above findings revealed a fact that NNT-AS1 affects breast cancer progression through modulating miR-142-3p/ZEB1 axis. |
pubmed id | 29710510 |
year | 2018 |
title | Long non-coding RNA NNT-AS1 affects progression of breast cancer through miR-142-3p/ZEB1 axis. |
drug | X |
circulating | X |
survival | V |
CopyRight © University of Miami, USA; Harbin Medical University, China